Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAYNIER MOYA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1124288980
CMS profile
278302
Location
PEMBROKE PINES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$15.30

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $15.30 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Exact Sciences Corporation $15.30 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAYNIER MOYA

NPI 1124288980 · CMS profile ID 278302

Allopathic & Osteopathic Physicians / Internal Medicine

PEMBROKE PINES, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124288980?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124288980?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124288980?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JAYNIER MOYA, NPI 1124288980, CMS profile ID 278302, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1124288980?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $15.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Exact Sciences Corporation $15.3009/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235445809 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $128.50 2
PY2023 $1,741.44 2
PY2025 $15.30 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $3,567,242.14 108
PY2024 Recipient $1,161.49 6
PY2024 Principal investigator $5,059,140.87 296
PY2023 Recipient $2,506.25 1
PY2023 Principal investigator $14,127,127.37 743
PY2022 Recipient $24,618.00 1
PY2022 Principal investigator $15,001,316.81 131
PY2021 Principal investigator $6,255,399.36 48
PY2020 Principal investigator $653,923.11 62
PY2019 Principal investigator $748,551.83 218

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

132 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $4,774.16 12/31/2022 Non-covered Recipient Entity
PINES CARE MEDICAL CENTER, LLC
A Phase 2b Multicenter Randomised Double blind Placebo controlled Study of Verinurad and Allopurinol in Patients with Chronic Kidney Disease and Hyperuricemia No dispute reported 06/30/2026 914599223
Principal investigator 1 PFIZER INC. $3,945.50 12/31/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949776575
Principal investigator 1 Bavarian Nordic A/S $146,976.30 12/21/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968153
Principal investigator 1 Janssen Research & Development, LLC $50,230.00 12/19/2022 Non-covered Recipient Entity
Pines Care Ctr
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 885222805
Principal investigator 1 Bavarian Nordic A/S $51,399.00 12/14/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968113
Principal investigator 1 Bavarian Nordic A/S $115,730.00 12/14/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968205
Principal investigator 1 Bavarian Nordic A/S $50,600.00 12/14/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968221
Principal investigator 1 Bavarian Nordic A/S $94,900.50 12/06/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968079
Principal investigator 1 PFIZER INC. $55.37 12/05/2022 Non-covered Recipient Entity
Pines Care Research Center Pines Care
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949761525
Principal investigator 1 Bavarian Nordic A/S $222,978.60 12/01/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968051
Principal investigator 1 PFIZER INC. $690.00 11/30/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949780369
Principal investigator 1 Janssen Research & Development, LLC $47,470.00 11/21/2022 Non-covered Recipient Entity
Pines Care Ctr
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 885222803
Principal investigator 1 Bavarian Nordic A/S $28,340.00 11/17/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968227
Principal investigator 1 Bavarian Nordic A/S $152,585.70 11/15/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968147
Principal investigator 1 PFIZER INC. $1,521.00 11/15/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949780109
Principal investigator 1 Bavarian Nordic A/S $30,505.50 11/08/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968101
Principal investigator 1 Boehringer Ingelheim International GmbH $130.00 11/04/2022 Non-covered Recipient Entity
Pines Care Research Center
Phase II dose finding PoCC in CKD No dispute reported 06/30/2026 965573173
Principal investigator 1 PFIZER INC. $3,120.00 11/03/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949780327
Principal investigator 1 Bavarian Nordic A/S $141,651.90 11/02/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968073
Principal investigator 1 PFIZER INC. $3,863.60 11/02/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949780371
Principal investigator 1 PFIZER INC. $4,134.00 10/28/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791757
Principal investigator 1 PFIZER INC. $965.90 10/27/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949791065
Principal investigator 1 Bavarian Nordic A/S $239,332.50 10/26/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968183
Principal investigator 1 Eli Lilly and Company $605,806.00 10/25/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917835327
Principal investigator 1 CHIESI USA, INC. $11,094.00 10/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A STUDY COMPARING EFFICACY, SAFETY AND TOLERABILITY OF THE FIXED DOSE TRIPLE COMBINATION CHF 5993 WITH THE FIXED DOSE DUAL COMBINATION CHF 1535 IN SUBJECTS WITH COPD (TRITON) No dispute reported 06/30/2026 957724987
Principal investigator 1 Bavarian Nordic A/S $423,730.80 10/18/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968165
Principal investigator 1 PFIZER INC. $11,459.50 10/18/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791755
Principal investigator 1 PFIZER INC. $4,829.50 10/14/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949791815
Principal investigator 1 Bavarian Nordic A/S $187,029.30 10/12/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968107
Principal investigator 1 Bavarian Nordic A/S $163,055.70 10/07/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968061
Principal investigator 1 PFIZER INC. $1,521.00 10/07/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791753
Principal investigator 1 PFIZER INC. $1,123,341.70 09/30/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949791389
Principal investigator 1 Bavarian Nordic A/S $489,966.30 09/28/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968217
Principal investigator 1 PFIZER INC. $315,495.70 09/24/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949791385
Principal investigator 1 PFIZER INC. $10,744.50 09/23/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791835
Principal investigator 1 PFIZER INC. $22,360.00 09/21/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791637
Principal investigator 1 Bavarian Nordic A/S $244,953.00 09/20/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968171
Principal investigator 1 GlaxoSmithKline, LLC. $466,684.38 09/19/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958171
Principal investigator 1 Bavarian Nordic A/S $52,661.70 09/14/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968141
Principal investigator 1 PFIZER INC. $32,318.00 09/14/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791387
Principal investigator 1 PFIZER INC. $2,086.50 09/10/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791635
Principal investigator 1 Bavarian Nordic A/S $179,795.70 09/09/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968089
Principal investigator 1 PFIZER INC. $27,622.00 09/09/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791633
Principal investigator 1 Bavarian Nordic A/S $785,880.00 09/07/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968067
Principal investigator 1 GlaxoSmithKline, LLC. $728.00 09/05/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958177
Principal investigator 1 GlaxoSmithKline, LLC. $910.00 08/29/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958161
Principal investigator 1 GlaxoSmithKline, LLC. $1,300.00 08/29/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958173
Principal investigator 1 GlaxoSmithKline, LLC. $6,502.60 08/29/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958175
Principal investigator 1 Bavarian Nordic A/S $71,264.70 08/23/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968177
Principal investigator 1 PFIZER INC. $4,524.00 08/23/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791531
Principal investigator 1 Bavarian Nordic A/S $310,895.40 08/22/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968187
Principal investigator 1 PFIZER INC. $23,098.00 08/19/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949791529
Principal investigator 1 Bavarian Nordic A/S $217,150.20 08/17/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968135
Principal investigator 1 PFIZER INC. $150,013.50 08/16/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949803989
Principal investigator 1 Bavarian Nordic A/S $117,117.00 08/11/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968119
Principal investigator 1 PFIZER INC. $2.76 08/10/2022 Non-covered Recipient Entity
Pines Care Research Center Pines Care
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949761711
Principal investigator 1 Bavarian Nordic A/S $149,350.50 08/09/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968084
Principal investigator 1 GlaxoSmithKline, LLC. $44,320.77 08/09/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958165
Principal investigator 1 GlaxoSmithKline, LLC. $942.50 08/08/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958169
Principal investigator 1 Bavarian Nordic A/S $352,506.60 08/02/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968055
Principal investigator 1 PFIZER INC. $201,070.20 07/29/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949806715
Principal investigator 1 Bavarian Nordic A/S $142,700.40 07/27/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968211
Principal investigator 1 Bavarian Nordic A/S $306,903.60 07/21/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968159
Principal investigator 1 GlaxoSmithKline, LLC. $942.50 07/19/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958163
Principal investigator 1 GlaxoSmithKline, LLC. $942.50 07/19/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP PHASE II STUDY No dispute reported 06/30/2026 943958167
Principal investigator 1 PFIZER INC. $5.52 07/13/2022 Non-covered Recipient Entity
Pines Care Research Center Pines Care
A PHASE 1 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF SELFAMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 949761523
Principal investigator 1 Bavarian Nordic A/S $127,062.00 07/12/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968125
Principal investigator 1 Bavarian Nordic A/S $216,982.80 07/08/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968095
Principal investigator 1 Bavarian Nordic A/S $148,564.80 06/30/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968199
Principal investigator 1 PFIZER INC. $89,424.70 06/29/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949813057
Principal investigator 1 Bavarian Nordic A/S $9,774.00 06/22/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968193
Principal investigator 1 Bavarian Nordic A/S $1,954.80 06/16/2022 Non-covered Recipient Entity
Pines Care Research Center, LLC
NCT05238025 No dispute reported 06/30/2026 906968129
Principal investigator 1 PFIZER INC. $178,179.30 06/15/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949813003
Principal investigator 1 PFIZER INC. $116,949.30 05/27/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949753653
Principal investigator 1 PFIZER INC. $255,091.20 05/14/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949753415
Principal investigator 1 PFIZER INC. $133,409.50 04/29/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949822365
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $998,203.10 04/15/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
Phase II dose finding PoCC in CKD No dispute reported 06/30/2026 949199391
Principal investigator 1 PFIZER INC. $57,283.90 04/14/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949822551
Principal investigator 1 PFIZER INC. $5,131.10 04/01/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949822367
Principal investigator 1 PFIZER INC. $4,095.00 03/23/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A 12WEEK PHASE 2A RANDOMIZED DOUBLEBLIND SPONSOROPEN PLACEBOCONTROLLED PARALLEL GROUP STUDY TO ASSESS THE SAFETY TOLERABILITY AND PHARMACODYNAMICS OF PF06882961 TITRATION IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH METFORMIN AND IN NONDIABETIC ADULTS WITH OBESITY No dispute reported 06/30/2026 949826687
Principal investigator 1 Janssen Research & Development, LLC $22,795.00 03/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A Phase 2b Randomized Double blind Placebo controlled Study to Evaluate the Efficacy and Safety of Rilematovir JNJ53718678 in Adult Outpatients with Respiratory Syncytial Virus RSV Infection who are at High Risk for RSV related Disease Progression No dispute reported 06/30/2026 885255591
Principal investigator 1 PFIZER INC. $277,829.50 03/16/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949826685
Principal investigator 1 PFIZER INC. $27,929.50 03/03/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A 12WEEK PHASE 2A RANDOMIZED DOUBLEBLIND SPONSOROPEN PLACEBOCONTROLLED PARALLEL GROUP STUDY TO ASSESS THE SAFETY TOLERABILITY AND PHARMACODYNAMICS OF PF06882961 TITRATION IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH METFORMIN AND IN NONDIABETIC ADULTS WITH OBESITY No dispute reported 06/30/2026 949826887
Recipient Eli Lilly and Company $24,618.00 02/25/2022 Covered Recipient Physician A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917807065
Principal investigator 1 PFIZER INC. $995,419.10 02/25/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949830011
Principal investigator 1 PFIZER INC. $24,420.00 02/18/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821447
Principal investigator 1 AstraZeneca Pharmaceuticals LP $13,341.90 02/17/2022 Non-covered Recipient Entity
PINES CARE MEDICAL CENTER, LLC
A Phase 2b Multicenter Randomised Double blind Placebo controlled Study of Verinurad and Allopurinol in Patients with Chronic Kidney Disease and Hyperuricemia No dispute reported 06/30/2026 914600795
Principal investigator 1 AstraZeneca Pharmaceuticals LP $503,049.25 02/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER, LLC
A Phase III Randomized Double-blind Placebo-controlled Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442 a Combination Product of Two Monoclonal Antibodies AZD8895 and AZD1061 for Post-exposure Prophylaxis of COVID-19 No dispute reported 06/30/2026 914591837
Principal investigator 1 PFIZER INC. $1,671,820.80 02/04/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949830055
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $21,454.00 01/28/2022 Non-covered Recipient Entity
Pines Care Research Center
Phase II dose finding PoCC in CKD No dispute reported 06/30/2026 965112357
Principal investigator 1 PFIZER INC. $910.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949820205
Principal investigator 1 PFIZER INC. $6,706.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949820281
Principal investigator 1 PFIZER INC. $980.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821451
Principal investigator 1 PFIZER INC. $6,227.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821729
Principal investigator 1 PFIZER INC. $6,706.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821731
Principal investigator 1 PFIZER INC. $980.00 01/21/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822369
Principal investigator 1 PFIZER INC. $6,706.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949820207
Principal investigator 1 PFIZER INC. $6,706.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949820285
Principal investigator 1 PFIZER INC. $6,706.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821449
Principal investigator 1 PFIZER INC. $910.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821543
Principal investigator 1 PFIZER INC. $6,227.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821627
Principal investigator 1 PFIZER INC. $980.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821743
Principal investigator 1 PFIZER INC. $980.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821807
Principal investigator 1 PFIZER INC. $980.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821913
Principal investigator 1 PFIZER INC. $6,227.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821915
Principal investigator 1 PFIZER INC. $700.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821929
Principal investigator 1 PFIZER INC. $6,706.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822241
Principal investigator 1 PFIZER INC. $6,227.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822243
Principal investigator 1 PFIZER INC. $6,227.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822245
Principal investigator 1 PFIZER INC. $6,227.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822265
Principal investigator 1 PFIZER INC. $980.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822269
Principal investigator 1 PFIZER INC. $910.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822313
Principal investigator 1 PFIZER INC. $910.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822423
Principal investigator 1 PFIZER INC. $910.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822445
Principal investigator 1 PFIZER INC. $4,790.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822447
Principal investigator 1 PFIZER INC. $980.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822585
Principal investigator 1 PFIZER INC. $6,706.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822589
Principal investigator 1 PFIZER INC. $910.00 01/20/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822645
Principal investigator 1 Eli Lilly and Company $1,678.00 01/11/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 917834359
Principal investigator 1 PFIZER INC. $293,012.20 01/08/2022 Non-covered Recipient Entity
Pines Care Research Center LLC
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 949831115
Principal investigator 1 PFIZER INC. $980.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949820283
Principal investigator 1 PFIZER INC. $980.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821545
Principal investigator 1 PFIZER INC. $6,706.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821629
Principal investigator 1 PFIZER INC. $6,706.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821733
Principal investigator 1 PFIZER INC. $560.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821745
Principal investigator 1 PFIZER INC. $6,706.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821747
Principal investigator 1 PFIZER INC. $6,706.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821809
Principal investigator 1 PFIZER INC. $6,706.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949821911
Principal investigator 1 PFIZER INC. $3,832.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822267
Principal investigator 1 PFIZER INC. $980.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822425
Principal investigator 1 PFIZER INC. $980.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822443
Principal investigator 1 PFIZER INC. $980.00 01/07/2022 Non-covered Recipient Entity
PINES CARE RESEARCH CENTER LLC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 949822587